95 results
It’s not magic, but the magnitude of benefit for psilocybin compared to other available treatments for major depressive disorder plus its relative lack of adverse effects suggests that this treatment might be about ready for prime time.
Personalized risk-based colorectal cancer screening would be ideal, but we may not yet be ready for such an approach. Find out why in this EBM Focus.
Is walking 8,000 steps one-two days per week sufficient to tack on a few extra years to your life? Maybe, but not necessarily based on this study. EBM Focus explains.
What global health issues should we keep an eye on in 2021? Dr. Stephen A. Berger co-founder of GIDEON (Global Infectious Diseases and Epidemiology Network) outlines five candidates that may re-emerge post-pandemic.
Long hospital stays are shown to contribute to rising healthcare costs and potential patient risks, but evidence-based medicine can help. Find out how.
While the COVID-19 pandemic continues to impact people worldwide, it is not the only coronavirus the world is battling in 2020. The MERS outbreak is still ongoing in the Middle East. Learn more about MERS from our partners at GIDEON.
DynaMed® Clinical Editor Dr. Katharine DeGeorge separates fact from fiction when it comes to measures to prevent SARS-CoV-2 transmission.
The medical library website connects users to the most relevant information for their search. How can you easily transform a medical library website into something of “research beauty”?
A new study on time-restricted eating (also known as intermittent fasting) enters the weight loss evidence ecosystem, but did the study investigators evaluate what they claim? The EBM Focus team at DynaMed investigates.
A new high-profile study seems to question the safety of sunscreen. Or does it?